DEXCOM INC is 8.1x more valuable than HAEMONETICS CORP by market capitalization ($28.85 B vs $3.58 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HAE | DXCM |
|---|---|---|
| Market cap | $3.58 B | $28.85 B |
| US-listed rank | #1668 | #473 |
| Revenue (latest FY) | $1.33B | $4.66B |
| Net income (latest FY) | $97.31M | $836.30M |
| Net margin | 7.3% | 17.9% |
| P/E (trailing FY) | 36.8 | 34.5 |
| SEC filings | 1,875 | 2,566 |
DEXCOM INC is 8.1x more valuable than HAEMONETICS CORP by market capitalization ($28.85 B vs $3.58 B).
In their latest fiscal years, HAEMONETICS CORP reported $1.33B in revenue while DEXCOM INC reported $4.66B.
Full pages: HAEMONETICS CORP and DEXCOM INC, or browse the full rankings.